富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/15 | 1,520 | 1,544 | 1,516 | 1,529 | +11 | +0.7% | 55,000 |
| 2024/05/14 | 1,530 | 1,530 | 1,503 | 1,518 | -26 | -1.7% | 98,800 |
| 2024/05/13 | 1,560 | 1,562 | 1,491 | 1,544 | -45 | -2.8% | 198,100 |
| 2024/05/10 | 1,481 | 1,615 | 1,478 | 1,589 | +26 | +1.7% | 348,100 |
| 2024/05/09 | 1,612 | 1,612 | 1,557 | 1,563 | -39 | -2.4% | 173,200 |
| 2024/05/08 | 1,601 | 1,604 | 1,586 | 1,602 | +2 | +0.1% | 88,600 |
| 2024/05/07 | 1,609 | 1,609 | 1,585 | 1,600 | -1 | -0.1% | 58,100 |
| 2024/05/02 | 1,606 | 1,607 | 1,591 | 1,601 | +5 | +0.3% | 48,700 |
| 2024/05/01 | 1,577 | 1,605 | 1,575 | 1,596 | +6 | +0.4% | 56,200 |
| 2024/04/30 | 1,571 | 1,596 | 1,558 | 1,590 | +38 | +2.4% | 47,800 |
| 2024/04/26 | 1,542 | 1,556 | 1,536 | 1,552 | +9 | +0.6% | 36,100 |
| 2024/04/25 | 1,570 | 1,570 | 1,543 | 1,543 | -29 | -1.8% | 44,800 |
| 2024/04/24 | 1,572 | 1,578 | 1,558 | 1,572 | +15 | +1% | 57,000 |
| 2024/04/23 | 1,553 | 1,557 | 1,541 | 1,557 | +20 | +1.3% | 66,000 |
| 2024/04/22 | 1,523 | 1,548 | 1,519 | 1,537 | +14 | +0.9% | 66,700 |
| 2024/04/19 | 1,541 | 1,546 | 1,506 | 1,523 | -29 | -1.9% | 79,000 |
| 2024/04/18 | 1,515 | 1,565 | 1,513 | 1,552 | +32 | +2.1% | 60,900 |
| 2024/04/17 | 1,540 | 1,544 | 1,515 | 1,520 | -30 | -1.9% | 93,200 |
| 2024/04/16 | 1,577 | 1,591 | 1,549 | 1,550 | -46 | -2.9% | 166,200 |
| 2024/04/15 | 1,570 | 1,598 | 1,566 | 1,596 | +16 | +1% | 49,500 |
| 2024/04/12 | 1,597 | 1,604 | 1,578 | 1,580 | -17 | -1.1% | 66,200 |
| 2024/04/11 | 1,600 | 1,604 | 1,585 | 1,597 | -18 | -1.1% | 51,800 |
| 2024/04/10 | 1,603 | 1,621 | 1,602 | 1,615 | +12 | +0.7% | 80,400 |
| 2024/04/09 | 1,570 | 1,607 | 1,570 | 1,603 | +33 | +2.1% | 78,500 |
| 2024/04/08 | 1,603 | 1,603 | 1,566 | 1,570 | -17 | -1.1% | 92,800 |
| 2024/04/05 | 1,585 | 1,593 | 1,570 | 1,587 | -19 | -1.2% | 90,200 |
| 2024/04/04 | 1,598 | 1,609 | 1,570 | 1,606 | +24 | +1.5% | 155,600 |
| 2024/04/03 | 1,586 | 1,600 | 1,559 | 1,582 | -21 | -1.3% | 154,200 |
| 2024/04/02 | 1,643 | 1,643 | 1,598 | 1,603 | -32 | -2% | 130,700 |
| 2024/04/01 | 1,660 | 1,660 | 1,625 | 1,635 | -21 | -1.3% | 95,100 |
| 2024/03/29 | 1,628 | 1,658 | 1,628 | 1,656 | +30 | +1.8% | 115,100 |
| 2024/03/28 | 1,630 | 1,635 | 1,612 | 1,626 | -10 | -0.6% | 65,200 |
| 2024/03/27 | 1,642 | 1,654 | 1,632 | 1,636 | -3 | -0.2% | 165,100 |
| 2024/03/26 | 1,617 | 1,640 | 1,611 | 1,639 | +16 | +1% | 102,100 |
| 2024/03/25 | 1,642 | 1,644 | 1,620 | 1,623 | -23 | -1.4% | 126,000 |
| 2024/03/22 | 1,678 | 1,678 | 1,637 | 1,646 | -31 | -1.8% | 174,800 |
| 2024/03/21 | 1,696 | 1,731 | 1,664 | 1,677 | -5 | -0.3% | 185,100 |
| 2024/03/19 | 1,678 | 1,694 | 1,671 | 1,682 | +11 | +0.7% | 80,000 |
| 2024/03/18 | 1,682 | 1,695 | 1,661 | 1,671 | -11 | -0.7% | 86,000 |
| 2024/03/15 | 1,680 | 1,687 | 1,661 | 1,682 | -5 | -0.3% | 111,900 |
| 2024/03/14 | 1,650 | 1,687 | 1,650 | 1,687 | +38 | +2.3% | 104,200 |
| 2024/03/13 | 1,659 | 1,661 | 1,621 | 1,649 | +3 | +0.2% | 127,200 |
| 2024/03/12 | 1,631 | 1,655 | 1,617 | 1,646 | +1 | +0.1% | 111,700 |
| 2024/03/11 | 1,676 | 1,682 | 1,621 | 1,645 | -47 | -2.8% | 175,400 |
| 2024/03/08 | 1,675 | 1,712 | 1,670 | 1,692 | -4 | -0.2% | 115,300 |
| 2024/03/07 | 1,719 | 1,728 | 1,685 | 1,696 | -16 | -0.9% | 143,500 |
| 2024/03/06 | 1,681 | 1,722 | 1,680 | 1,712 | +31 | +1.8% | 185,100 |
| 2024/03/05 | 1,665 | 1,682 | 1,644 | 1,681 | +9 | +0.5% | 152,400 |
| 2024/03/04 | 1,702 | 1,702 | 1,661 | 1,672 | -31 | -1.8% | 208,200 |
| 2024/03/01 | 1,742 | 1,742 | 1,703 | 1,703 | -51 | -2.9% | 185,000 |
251～
300
件表示中 / 6958件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 63,900円 | -9.6% | -30.2% | 4.69% | 25.83倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,900円 | +150.0% | - | 0.00% | - | 16.18倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
